SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (335)4/20/1998 8:54:00 PM
From: Dr. John M. de Castro  Respond to of 1494
 
NTI received orphan drug status for xerecept.

biz.yahoo.com

There are some who think that this is a potentially a far
greater revenue producer in the future for NTI than memantine.
The orphan drug status protects that revenue for 7 years.

I haven't been able to find out when the Phase II will be completed.
Does anyone have any insight into this.

John de C